Intelligent Bio Solutions Inc. - SIC # 3840 -

Ticker Exchange SIC # Website Latest Ticker
INBS Nasdaq 3840 ibs.inc

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites - Jan 14th, 2025 1:30 pm
Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology - Dec 18th, 2024 1:30 pm
Intelligent Bio Solutions to Host Virtual Fireside Chat on Wednesday, December 11th at 4:30 p.m. ET - Dec 4th, 2024 1:30 pm
Intelligent Bio Solutions completes fingerprint drug screening system study - Nov 27th, 2024 11:28 am
Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results - Nov 26th, 2024 1:30 pm
Intelligent Bio Solutions to Participate in the Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference - Nov 21st, 2024 1:30 pm
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study - Nov 18th, 2024 3:55 pm
Intelligent gears up for FDA approval of fingerprint drug detection device - Nov 14th, 2024 12:19 pm
Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission - Nov 13th, 2024 1:30 pm
Intelligent Bio Solutions First Quarter 2025 Earnings: US$0.70 loss per share (vs US$12.49 loss in 1Q 2024) - Nov 10th, 2024 1:33 pm
Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights - Nov 7th, 2024 1:30 pm
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach - Nov 1st, 2024 11:28 pm
Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results - Oct 29th, 2024 12:30 pm
Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil - Oct 24th, 2024 12:30 pm
Intelligent Bio Solutions to Present at the LD Micro Main Event XVII on October 28-30 in Los Angeles - Oct 16th, 2024 12:00 pm
Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek - Oct 14th, 2024 12:00 pm
Intelligent Bio Solutions Partners with Spirit Group as Australian Distributor, Expanding Community Impact with Intelligent Fingerprinting Drug Testing Solution - Oct 9th, 2024 12:30 pm
GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services - Oct 1st, 2024 12:30 pm
Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission - Sep 27th, 2024 12:30 pm
UK’s Largest Greenhouse Complex, Thanet Earth, Adopts Intelligent Bio Solutions’ Fingerprint Drug Test to Enhance Workplace Safety - Sep 25th, 2024 12:30 pm